RESUMO
BACKGROUND AND AIMS: Obesity is associated with increased risks of cardiovascular disease, type 2 diabetes, and other chronic diseases. Prevalence estimates for metabolic disorders are well documented in many populations, but Alaska Native groups are understudied. The Western Alaska Tribal Collaborative for Health Study combines data from three Alaska Native study cohorts to assess differences in obesity prevalence and associations with cardiometabolic risk factors by sex. METHODS AND RESULTS: Analyses were based upon a sample of 3985 adult Yup'ik and Inupiat participants with a mean age of 40 years. Prevalence of obesity and metabolic risk factors was assessed according to nationally recognized guidelines. Regression analysis was used to evaluate the association between obesity and cardiometabolic risk factors, including lipids, blood pressure and glucose. The prevalence of obesity (BMI ≥ 30) was significantly higher in women (40%) than men (20%). Only 18.6% of men had a waist circumference (WC) > 102 cm, while 58% of women had a WC > 88 cm (p < 0.001). Women had higher mean HDL-C and triglyceride levels compared to men, while systolic and diastolic blood pressure, LDL-C, and glucose means were higher in men than in women. In multivariate analyses, BMI and WC were significantly associated with all of the cardiometabolic risk factors, although these associations were more pronounced in men than women. CONCLUSION: The high prevalence of obesity and central adiposity among AN women is an important public health concern. Differences in associations between obesity and cardiometabolic risk factors by sex warrants further investigation to develop effective intervention programs.
Assuntos
Doenças Cardiovasculares/etnologia , Síndrome Metabólica/etnologia , Obesidade/etnologia , Fatores Sexuais , Adulto , Alaska/epidemiologia , Glicemia/metabolismo , Pressão Sanguínea , Índice de Massa Corporal , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Estudos de Coortes , Feminino , Humanos , Inuíte , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Prevalência , Análise de Regressão , Fatores de Risco , Triglicerídeos/sangue , Circunferência da Cintura , Adulto JovemRESUMO
AIM: To evaluate whether uric acid (UA) predicts 4-yr incidence of metabolic syndrome (MetS) in non-diabetic participants of the Strong Heart Study (SHS) cohort. METHODS AND RESULTS: In this population-based prospective study we analyzed 1499 American Indians (890 women), without diabetes or MetS, controlled during the 4th SHS exam and re-examined 4 years later during the 5th SHS exam. Participants were divided into sex-specific tertiles of UA and the first two tertiles (group N) were compared with the third tertile (group H). Body mass index (BMI = 28.3 ± 7 vs. 31.1 ± 7 kg/m(2)), fat-free mass (FFM = 52.0 ± 14 vs. 54.9 ± 11 kg), waist-to-hip ratio, HOMA-IR (3.66 vs. 4.26), BP and indices of inflammation were significantly higher in group H than in group N (all p < 0.001). Incident MetS at the time of the 5th exam was more frequent in group H than group N (35 vs. 28%, OR 1.44 (95% CI = 1.10-1.91; p < 0.01). This association was still significant (OR = 1.13, p = 0.04) independently of family relatedness, sex, history of hypertension, HOMA-IR, central adiposity and renal function, but disappeared when fat-free mass was included in the model. CONCLUSIONS: In the SHS, UA levels are associated to parameters of insulin resistance and to indices of inflammation. UA levels, however, do not predict incident MetS independently of the initial obesity-related increased FFM.
Assuntos
Síndrome Metabólica/sangue , Síndrome Metabólica/epidemiologia , Obesidade/sangue , Obesidade/epidemiologia , Ácido Úrico/sangue , Idoso , Composição Corporal , Índice de Massa Corporal , Estudos de Coortes , Feminino , Humanos , Hipertensão/epidemiologia , Indígenas Norte-Americanos , Masculino , Pessoa de Meia-Idade , Obesidade Abdominal/epidemiologia , Valor Preditivo dos Testes , Prevalência , Estudos Prospectivos , Fatores Sexuais , Relação Cintura-QuadrilRESUMO
The placebo effect has not been characterised in pregnant women suffering from nausea and vomiting of pregnancy (NVP). Our aim was to characterise determinants of the placebo effect in women treated with placebo for NVP. We analysed data from a multicentre, double blind randomised controlled trial of Diclectin (delayed release doxylamine and pyridoxine) vs placebo for the treatment of NVP. A total of 127 women in the placebo arm and 130 in the active arm provided evaluable data for this analysis. Women who chose to continue placebo on a compassionate basis (n = 41) had significantly better improvement in symptoms of NVP and higher Wellbeing scores than those who did not ask to continue compassionate use. Results were similar in the active drug arm. The request to continue compassionate use of either placebo or active drug could be predicted by greater improvement in symptoms of NVP during the trial period.
Assuntos
Diciclomina/uso terapêutico , Doxilamina/uso terapêutico , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Êmese Gravídica/tratamento farmacológico , Efeito Placebo , Piridoxina/uso terapêutico , Adulto , Método Duplo-Cego , Combinação de Medicamentos , Feminino , Humanos , Modelos Logísticos , Gravidez , Ensaios Clínicos Controlados Aleatórios como Assunto , Adulto JovemRESUMO
The vascular pathophysiology of preeclampsia, a hypertensive disorder unique to human pregnancy, has been postulated to be due to endothelial dysfunction, primarily manifest as deficient nitric oxide (NO) synthesis. We evaluated contraction (KCl and arginine vasopressin [AVP]) and dilation (acetylcholine and bradykinin) in small resistance-size omental arteries obtained during surgery from women with preeclampsia, postulating that these vessels would exhibit augmented contraction and diminished endothelium-dependent relaxation, most likely due to decreased NO synthesis. For comparison, vessels were also obtained from normotensive gravidas, pregnant women with chronic hypertension, or with chronic hypertension and superimposed preeclampsia, as well as from premenopausal nonpregnant controls. Vessels of approximately 200 micron in internal diameter were studied in vitro using a Mulvany-Halpern myograph. Maximal contraction due to either KCl or AVP was significantly augmented in vessels from women with preeclampsia; these vessels all exhibited endothelium- and cyclooxygenase-dependent phasic oscillations while vessels from all other groups exhibited only tonic contractions. Acetylcholine and bradykinin both led to dose- and endothelium-dependent relaxation which was unaffected by inhibitors of NO synthesis. Responses to bradykinin were similar in vessels from normal pregnant and preeclamptic women while those to acetylcholine were absent in vessels from women with preeclampsia. These data suggest specific defects in resistance-artery endothelium from women with preeclampsia.
Assuntos
Endotélio Vascular/fisiologia , Pré-Eclâmpsia/fisiopatologia , Vasodilatação , Acetilcolina/farmacologia , Adulto , Arginina Vasopressina/farmacologia , Artérias/fisiopatologia , Bradicinina/farmacologia , Feminino , Humanos , Óxido Nítrico/fisiologia , Nitroarginina/farmacologia , Omento/irrigação sanguínea , Gravidez , Vasodilatação/efeitos dos fármacosRESUMO
Cadmium (Cd) is an environmental pollutant that has been associated with cardiovascular disease in populations, but the relationship of Cd with hypertension has been inconsistent. We studied the association between urinary Cd concentrations, a measure of total body burden, and blood pressure in American Indians, a US population with above national average Cd burden. Urinary Cd was measured using inductively coupled plasma mass spectrometry, and adjusted for urinary creatinine concentration. Among 3714 middle-aged American Indian participants of the Strong Heart Study (mean age 56 years, 41% male, 67% ever-smokers, 23% taking antihypertensive medications), urinary Cd ranged from 0.01 to 78.48 µg g-1 creatinine (geometric mean=0.94 µg g-1) and it was correlated with smoking pack-year among ever-smokers (r2=0.16, P<0.0001). Participants who were smokers were on average light-smokers (mean 10.8 pack-years), and urinary Cd was similarly elevated in light- and never-smokers (geometric means of 0.88 µg g-1 creatinine for both categories). Log-transformed urinary Cd was significantly associated with higher systolic blood pressure in models adjusted for age, sex, geographic area, body mass index, smoking (ever vs never, and cumulative pack-years) and kidney function (mean blood pressure difference by lnCd concentration (ß)=1.64, P=0.002). These associations were present among light- and never-smokers (ß=2.03, P=0.002, n=2627), although not significant among never-smokers (ß=1.22, P=0.18, n=1260). Cd was also associated with diastolic blood pressure among light- and never-smokers (ß=0.94, P=0.004). These findings suggest that there is a relationship between Cd body burden and increased blood pressure in American Indians, a population with increased cardiovascular disease risk.
Assuntos
Pressão Sanguínea , Cádmio/urina , Hipertensão/urina , Indígenas Norte-Americanos/estatística & dados numéricos , Carga Corporal (Radioterapia) , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
We assessed mechanisms of acetylcholine- and bradykinin-induced relaxations in human omental resistance vessels. Ring segments (approximately 200 microns normalized ID) were dissected from omental biopsies obtained from women at laparotomy (nonpregnant) or at cesarean delivery (pregnant) and were studied under isometric conditions in a Mulvany-Halpern myograph. All arginine vasopressin-preconstricted vessels relaxed in a strictly endothelium-dependent manner to acetylcholine and bradykinin; maximal relaxations were not decreased by either NG-nitro-L-arginine or indomethacin. By contrast, bradykinin failed to relax vessels that had been preconstricted with potassium gluconate. In the combined presence of NG-nitro-L-arginine and indomethacin, addition of charybdotoxin, a selective antagonist of some calcium-sensitive potassium channels, did not inhibit maximal bradykinin-induced relaxation. By contrast, addition of 10 mmol/L tetraethylammonium chloride abolished relaxation in vessels from nonpregnant women but not in vessels from gravidas. We conclude that bradykinin relaxes these human resistance arteries in an endothelium-dependent but predominantly nitric oxide- and prostanoid-independent manner; relaxation likely depends on the action of an endothelium-derived hyperpolarizing vasodilator. Furthermore, in striking contrast to mechanistic insights from animal studies, human pregnancy appears to augment a mechanism of endothelium-dependent relaxation in these vessels that is insensitive to the inhibitors noted above. Whether a similar novel vasodilator mechanism in vivo contributes to the physiological vasodilation that characterizes human gestation or whether failure of such a mechanism might lead to preeclampsia remains the subject of future study.
Assuntos
Acetilcolina/farmacologia , Bradicinina/farmacologia , Relaxamento Muscular/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Omento/irrigação sanguínea , Adulto , Arginina/análogos & derivados , Arginina/farmacologia , Arteríolas/efeitos dos fármacos , Interações Medicamentosas , Inibidores Enzimáticos/farmacologia , Feminino , Humanos , Indometacina/farmacologia , Óxido Nítrico/metabolismo , Nitroarginina , GravidezRESUMO
It has remained unclear whether well-dialyzed patients with end-stage renal disease (ESRD) show persisting neurocognitive deficits, especially in tasks that depend on sustained attention or psychomotor speed. We administered a battery of six attentional measures to 10 stable hemodialysis (HD) patients (age, 61+/-16 years; education, 12.4+/-3.8 years; Kt/V, 1.35+/-0.07) and 10 matched controls with normal renal function (age, 62+/-10 years; education, 11.6+/-1.0 years; estimated creatinine clearance, 92+/-25 mL/min). Results of the Trailmaking Test, Paced Auditory Serial Addition Test, Stroop Test, Digit Span, Continuous Performance Test (CPT), and Gordon Diagnostic System did not differ between groups. We conclude it is unlikely that well-dialyzed patients with ESRD manifest significant uremic neurocognitive deficits in the functional spheres related to sustained attention or mental processing speed.
Assuntos
Atenção/fisiologia , Processos Mentais/fisiologia , Diálise Renal , Estudos de Casos e Controles , Cognição/fisiologia , Depressão/psicologia , Escolaridade , Humanos , Falência Renal Crônica/psicologia , Falência Renal Crônica/terapia , Pessoa de Meia-Idade , Desempenho Psicomotor/fisiologia , Tempo de Reação , Fatores de TempoRESUMO
Recently, we demonstrated that chronic exposure to hyperoxia causes in vivo airway muscarinic receptor hyperresponsiveness in the developing rat [Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L263-L269, 1992]. To test whether airway cholinergic hyperresponsiveness might result from intrinsic alterations in smooth muscle contractility, we measured the effect of in vivo hyperoxia on the contractile force elicited by acetylcholine (ACh) of isometrically mounted tracheal rings in vitro. Tracheal rings were obtained from 3-wk-old rats exposed to air or to > 95% O2 for 8 days. Muscarinic responses were determined by measuring the force elicited by exposure to increasing concentrations of ACh. Responses were normalized to the morphometrically determined tracheal smooth muscle cross-sectional area in a plane perpendicular to the axis of force generation. In vivo O2 exposure significantly increased maximal ACh-induced stress generation (response to 10(-3) M ACh: air, 15.92 +/- 1.37 g/mm2; O2, 21.78 +/- 1.52 g/mm2; P = 0.010). The ACh-induced stress generation of cylinders from hyperoxic rats was substantially reduced by both epithelial removal and treatment with the cyclooxygenase inhibitor indomethacin. We conclude that in vivo hyperoxic exposure increases tracheal smooth muscle contractile function in vitro and that epithelium-derived prostaglandin(s) contributes to the observed increase in maximal contractile responsiveness.
Assuntos
Músculo Liso/fisiopatologia , Oxigênio/metabolismo , Hipersensibilidade Respiratória/etiologia , Traqueia/fisiopatologia , Animais , Animais Recém-Nascidos , Técnicas de Cultura , Inibidores de Ciclo-Oxigenase/farmacologia , Inibidores de Lipoxigenase , Mucosa/fisiologia , Contração Muscular , Ratos , Ratos Sprague-Dawley , Estresse MecânicoRESUMO
Opioid agonists routinely increase the latency to respond in the rodent tailflick assay. The nature of this effect was investigated in 5 experiments using several parametric variations and routes of administration. Morphine and methadone were found to produce both quantal and graded effects in all experiments. In cases where quantal effects were observed, the majority of animals also responded in a graded manner during subsequent testing. The increase in latency to respond in the tailflick assay produced by opioid agonists is not accurately characterized as predominantly quantal.
Assuntos
Metadona/uso terapêutico , Morfina/uso terapêutico , Dor/tratamento farmacológico , Animais , Relação Dose-Resposta a Droga , Cinética , Masculino , Metadona/farmacologia , Morfina/farmacologia , Ratos , Tempo de Reação/efeitos dos fármacosRESUMO
Contractile responses to KCl or phenylephrine were inhibited in endothelium-denuded aorta from endotoxin-treated rats. L-Canavanine, a selective inhibitor of inducible nitric oxide synthase, augmented contractile responses in vessels from endotoxin, but not saline-pretreated animals. In contrast to nitroarginine, L-canavanine did not inhibit endothelium-dependent relaxation induced by acetylcholine. Selective inhibitors of inducible nitric oxide synthase may be useful probes of vascular dysfunction in sepsis.
Assuntos
Bacteriemia/metabolismo , Canavanina/farmacologia , Contração Muscular/efeitos dos fármacos , Músculo Liso Vascular/efeitos dos fármacos , Animais , Arginina/análogos & derivados , Arginina/farmacologia , Endotélio Vascular/fisiologia , Lipopolissacarídeos , Masculino , Nitroarginina , Cloreto de Potássio/farmacologia , Ratos , Ratos EndogâmicosRESUMO
The acute toxicity of heroin (3,6-diacetylmorphine, DAM) and its metabolites 6-acetylmorphine (AM) and morphine (M) following intravenous (i.v.) and intracerebroventricular (i.c.v.) administration and their tailflick-test analgesic activity following i.c.v. administration were studied in mice. After i.c.v. administration, M was 2.5-3 times more potent as a naloxone-reversible analgesic than either DAM or AM. DAM and AM provoked a naloxone-sensitive respiratory depressant lethality (i.c.v.) while M (i.c.v.), and all three drugs given i.v., caused convulsions prior to death. The dose-response and naloxone antagonism studies suggest that the receptor mechanisms which may subserve opiate convulsions differ from those mediating either analgesia or depressant lethality. Studies of DAM's disposition in vivo and in vitro suggest that unhydrolyzed DAM may contribute to its own pharmacodynamic profile after i.v., but not subcutaneous (s.c.) administration to mice.
Assuntos
Analgesia , Heroína/toxicidade , Animais , Relação Dose-Resposta a Droga , Heroína/metabolismo , Heroína/farmacologia , Técnicas In Vitro , Masculino , Camundongos , Camundongos Endogâmicos , Morfina/metabolismo , Morfina/toxicidade , Derivados da Morfina/metabolismo , Derivados da Morfina/toxicidadeRESUMO
The effects of methadone and morphine on fetal behavior were studied following their administration to either the mother (5micrograms/kg/min) or fetus (0.5micrograms/kg maternal wt./min) using the chronically-instrumented pregnant ewe model. Fourteen unanesthetized, unrestrained pregnant ewes between 130-141 days gestation (term 145 days) were studied 9-28 days following the surgical implantation of cannulae and electrodes to monitor fetal heart rate, blood pressure, breathing movements, eye movements, muscular and electrocortical activity. The three behavioral states of quiet sleep, rapid eye movement sleep and arousal could be distinguished using these parameters. Both drugs, by both routes, resulted in fetal arousal, largely at the expense of quiet sleep. While morphine and methadone were equipotent in suppressing quiet sleep following infusion to the fetus, methadone was three times more potent than morphine after maternal infusion. This potency difference is consistent with the results of prior pharmacokinetic studies demonstrating that fetal exposure to maternally administered methadone is approximately three times greater than that to maternally administered morphine.
Assuntos
Feto/fisiologia , Metadona/farmacologia , Morfina/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Feminino , Coração Fetal/efeitos dos fármacos , Coração Fetal/fisiologia , Feto/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Troca Materno-Fetal , Gravidez , OvinosRESUMO
We sought to delineate contributions of nitric oxide (NO) and other mechanisms to impairment of contraction and endothelium-dependent relaxation following prolonged in vitro incubation, endotoxin and interleukin-1 exposure in isolated rat aorta. Responses from freshly-dissected (control) rings +/-endothelium were compared with those from rings incubated in sterile, antibiotic containing medium +/- E. Coli endotoxin (LPS, 100 microg/ml) +/- interleukin-1 (IL-1, 40 ng/ml) at 37 degrees C for 20-24 h. In some experiments, medium included dexamethasone (DEX, 1 microg/ml), cycloheximide (10 microg/ml), or N(G)-nitro-L-arginine (NNLA, 10(-4)M). After incubation, medium nitrite was measured. Incubation alone, without addition of inflammatory mediators, impaired contraction in an agonist-specific manner, by both NO-dependent and NO-independent mechanisms. Either LPS or IL-1 diminished contraction further, in a similarly heterogeneous manner. For example, contractions were changed in LPS-incubated endothelium-intact rings (vs. fresh controls) by -85%, +115%, -15%, -96%, and -37% for phenylephrine (PE), serotonin, prostaglandin F2alpha, angiotensin II, and U46619, respectively. NO synthase inhibition with NNLA either following, or during LPS incubation only partially normalized subsequent PE contractions, an effect which was smaller than that of DEX. Nitrite accumulation was inversely proportional to PE response, even though NO was not the sole mediator of LPS-impaired contraction. LPS and IL-1 nearly abolished ACh-induced relaxation, which was only mildly impaired by incubation alone. We conclude that prolonged incubation impaired vasoconstriction via both NO synthase induction and NO-independent mechanisms. LPS or IL-1 incubation impaired vasoconstriction further, primarily by NO-independent mechanisms. Moreover, vasoconstrictor responses following LPS varied with the agonist's ability to modulate endothelial NO release. These results are in accord with the failure of NO synthase inhibition to fully restore systemic vascular resistance indices in experimental endotoxemia or in hyperdynamic septic patients.
Assuntos
Aorta Torácica/efeitos dos fármacos , Endotoxinas/farmacologia , Óxido Nítrico/farmacologia , Vasoconstrição/efeitos dos fármacos , Vasodilatação/efeitos dos fármacos , Animais , Aorta Torácica/metabolismo , Meios de Cultivo Condicionados/química , Meios de Cultivo Condicionados/metabolismo , Cicloeximida/farmacologia , Dexametasona/farmacologia , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Glucocorticoides/farmacologia , Técnicas In Vitro , Interleucina-1/farmacologia , Masculino , Óxido Nítrico/metabolismo , Nitritos/análise , Nitroarginina/farmacologia , Inibidores da Síntese de Proteínas/farmacologia , Ratos , Ratos Sprague-Dawley , Vasoconstrição/fisiologia , Vasoconstritores/farmacologia , Vasodilatação/fisiologia , Vasodilatadores/farmacologiaRESUMO
We reported previously that acetylcholine (ACh)-induced endothelium-dependent relaxation of rat mesenteric microvessels depended both on nitric oxide (NO) and on a charybdotoxin (CTX)-sensitive endothelium-derived hyperpolarizing vasodilator. Cytochrome P450 (CYP)-dependent arachidonic acid metabolites act in some systems as hyperpolarizing vasodilators. We sought to quantitate contributions of such metabolites to the CTX-sensitive component of ACh-induced vasodilation in isolated rat mesenteric resistance arteries. ACh relaxed these vessels nearly completely (93.3+/-1.2%, n = 71); cyclooxygenase inhibition with indomethacin did not diminish this response (94.3+/-11.4%, n = 9). NO synthase inhibition with Nitro-L-arginine (NNLA) reduced relaxation by 30% (n = 54, p<0.05). Pretreatment of vessels with CYP inhibitors, either clotrimazole (CTM) or 17-octadecynoic acid (17-ODYA), or with selective K+ channel inhibitors, either tetraethyammonium acetate (TEA) or CTX, each led to similar small reductions in maximal relaxation (17%, 22%, 16%, and 9% respectively, n = 3-6). Combined pretreatment with NNLA + either (CTM or 17-ODYA) or (TEA or CTX) each led to similar maximal relaxations (52.2+/-4.8%, 50.6+/-9.2, 37.6+/-8.6%, and 44.1+/-11.5%, respectively, n = 6-35; p<0.05 for NNLA+[CTM or TEA or CTX] vs NNLA alone). Combined pretreatment with NNLA+CTM+(CTX or TEA) led to similar maximal relaxations (43.0+/-7.3%, 43.7+/-15%, n = 6-11) that did not differ from values in vessels pretreated with either NNLA+CTM or NNLA+(CTX or TEA). We conclude that the ACh-induced vasodilation was insensitive to cyclooxygenase inhibition, partially sensitive to NO synthase inhibition, and that the K+ channel blockers TEA and CTX identified the same minor component of ACh relaxation as did the CYP inhibitor CTM.
Assuntos
Sistema Enzimático do Citocromo P-450/fisiologia , Endotélio Vascular/fisiologia , Artérias Mesentéricas/fisiologia , Vasodilatação/fisiologia , Acetilcolina/farmacologia , Animais , Arginina Vasopressina/farmacologia , Charibdotoxina/antagonistas & inibidores , Charibdotoxina/farmacologia , Inibidores das Enzimas do Citocromo P-450 , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Inibidores Enzimáticos/farmacologia , Masculino , Óxido Nítrico/fisiologia , Óxido Nítrico Sintase/antagonistas & inibidores , Canais de Potássio/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Vasodilatação/efeitos dos fármacosRESUMO
The relative affinity to opiate receptors of heroin, 6-acetylmorphine and morphine was estimated by determining their ability to displace specifically bound 3H-naltrexone from rat brain opiate binding sites. In vitro hydrolysis of heroin to 6-acetylmorphine was monitored in the binding assay filtrate by use of a quantitative HPLC procedure. The rate of heroin hydrolysis was significantly slower at 0 degrees C than at 37 degrees C. The displacement of 1 nM 3H-naltrexone by unlabeled ligand at concentrations ranging from 7 to 500 nM was measured at 0 degrees C for 120 minutes, yielding IC50 values of heroin = 483 nM, 6-acetylmorphine = 73 nM and morphine = 53 nM. When the binding data for heroin were recalculated to include the displacement that could be attributed to the 6-acetylmorphine derived from heroin degradation during the incubation, all of the apparent heroin binding was accounted for by the 6-acetylmorphine. These results are consistent with previous reports of the low binding affinity of morphine congeners (e.g., codeine) that lack a free phenolic 3-hydroxyl group and support the view that heroin is a prodrug which serves to determine the distribution of its intrinsically active metabolites, 6-acetylmorphine and morphine.
Assuntos
Encéfalo/metabolismo , Heroína/metabolismo , Receptores Opioides/metabolismo , Animais , Membrana Celular/metabolismo , Heroína/farmacologia , Masculino , Morfina/farmacologia , Derivados da Morfina/farmacologia , Naltrexona/metabolismo , Ratos , Ratos Endogâmicos , Receptores Opioides/efeitos dos fármacos , Relação Estrutura-AtividadeRESUMO
The binding of methadone to maternal and fetal plasma proteins was determined throughout the third trimester in the pregnant ewe. Blood was sampled from chronic indwelling catheters placed in the maternal aorta and fetal aorta. Methadone binding was determined by use of equilibrium dialysis with (3H)-methadone. Maternal binidng ranged from 50.4 to 89.5%, with a mean of 76.2 +/- 1.3 (SE)%. Fetal binding was initially significantly lower than maternal binding, but increased rapidly in the last two weeks before parturition. Prior to 130 days gestation, the ratio of fetal binding to maternal binding was 0.40 +/- 0.03. This binding ratio increased to 0.82 +/- 0.08 in the last few days of pregnancy. Preliminary results suggested that maternal binding was higher in the early post-partum period. These results demonstrate that the relationship between maternal and fetal plasma binding of methadone changes rapidly towards the end of pregnancy, and fetal binding approaches maternal binding at parturition.
Assuntos
Proteínas Sanguíneas/metabolismo , Troca Materno-Fetal , Metadona/sangue , Ovinos/sangue , Animais , Feminino , Feto/fisiologia , Idade Gestacional , Gravidez , Ovinos/embriologiaRESUMO
OBJECTIVE: To compare connexin expression in omental resistance arteries from preeclamptic women and normal gravidas. METHODS: Small arteries (approximately 200-400 microm i.d.) were dissected from omental fat biopsies, taken at cesarean delivery from normotensive and preeclamptic women. Vessels were frozen and homogenized, then connexin-43 protein was detected by Western blot and quantitated by comparison with alpha-actin. RESULTS: Connexin-43 was detected in all specimens, primarily in its phosphorylated form. Abundance did not differ between vessels from preeclamptic and normotensive gravidas. CONCLUSIONS: Phasic activity in omental resistance vessels from preeclamptic women likely depends on abnormal genesis of an oscillatory signal rather than on more extensive gap junctional communication between vascular cells.
Assuntos
Conexina 43/metabolismo , Omento/irrigação sanguínea , Pré-Eclâmpsia/metabolismo , Adulto , Artérias/metabolismo , Western Blotting , Feminino , Humanos , GravidezRESUMO
Physiological changes in pregnancy, including changes in body composition and metabolic enzyme activity, can alter drug pharmacokinetics. A semi-mechanistic metabolism model was developed to describe the pharmacokinetics of two cytochrome P450 3A (CYP3A) substrates, midazolam and nifedipine, in obstetrics patients. The model parameters were optimized to fit the data of oral midazolam pharmacokinetics in pregnant women, by increasing CYP3A-induced hepatic metabolism 1.6-fold in the model with no change in gut wall metabolism. Fetal metabolism had a negligible effect on maternal plasma drug concentrations. Validation of the model was performed by applying changes in volume of distribution and metabolism, consistent with those observed for midazolam, to the pharmacokinetics parameters of immediate-release nifedipine in healthy volunteers. The predicted steady-state areas under the concentration-time curve (AUCs) for nifedipine were within 15% of the data observed in pregnant women undergoing treatment for preterm labor. This model predicts the pharmacokinetics of two CYP3A substrates in pregnancy, and may be applicable to other CYP3A substrates as well.CPT: Pharmacometrics & Systems Pharmacology (2012) 1, e2; doi:10.1038/psp.2012.5; advance online publication 26 September 2012.
RESUMO
Intermittent hemodialysis is the primary supportive therapy for patients with end-stage renal disease, who commonly receive several drugs to treat both their underlying disease and the conditions that arise during long-term hemodialysis therapy. Many of these drugs are dialyzable, and their hemodialytic removal may compromise therapeutic efficacy if appropriate supplementary doses are not given. Emergency hemodialysis may also be life-saving for patients who have received drug overdoses or have ingested toxic substances. Optimal therapy in both these clinical settings is critically dependent on the availability of reliable information from well-designed pharmacokinetic studies.